A Food and Drug Administration committee wants a new label for certain pain relievers, including Aleve, following evidence from trial data that Naproxen carries a lower cardiovascular risk than other ... more 
A Food and Drug Administration committee wants a new label for certain pain relievers, including Aleve, following evidence from trial data that Naproxen carries a lower cardiovascular risk than other drugs in that category. Dr. David Agus, author of "A Short Guide to a Long Life," talks to the "CBS This Morning" co-hosts about the findings. less 
1 / 8
CBSTV Videos
Wed, Jan 29, 2014 2:43 PM EST